Canada markets closed

Evofem Biosciences, Inc. (EVFM)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.0168+0.0026 (+17.96%)
At close: 03:58PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
18,218
18,218
16,837
8,244
446
Cost of Revenue
6,512
6,512
4,415
4,055
468
Gross Profit
11,706
11,706
12,422
4,189
-22
Operating Expenses
Research Development
2,939
2,939
25,032
33,129
17,050
Selling General and Administrative
26,614
26,614
71,514
137,861
86,552
Total Operating Expenses
29,553
29,553
96,546
170,990
103,602
Operating Income or Loss
-17,847
-17,847
-84,124
-166,801
-103,624
Total Other Income/Expenses Net
70,812
70,812
7,385
-38,389
-38,850
Income Before Tax
52,996
52,996
-76,654
-205,175
-142,305
Income Tax Expense
17
17
44
17
4
Income from Continuing Operations
52,979
52,979
-76,698
-205,192
-142,309
Net Income
52,979
52,979
-76,698
-205,192
-142,309
Net Income available to common shareholders
49,995
49,995
-78,014
-206,239
-142,309
Basic EPS
60.30
-
-167.42
-2.95k
-3.97k
Diluted EPS
38.97
-
-167.42
-2.95k
-3.97k
Basic Average Shares
2,117
-
465.967
69.818
35.817
Diluted Average Shares
521,146
-
465.967
69.818
35.817